Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
The nucleus basalis of Meynert provides diffuse cholinergic input to the neocortex. When compared with an age‐ and sex‐matched control, the nucleus basalis from a patient with Alzheimer disease demonstrated substantial reduction of neurons. Loss of this neuronal population may represent an anatomical correlate of the well‐documented cholinergic derangement in Alzheimer disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A further pathological determinant is loss of neurons, which occurs predominantly in the cortex, the hippocampal formation, and the nucleus basalis of Meynert [2, 3, 18, 22, 25].”
From Transient intraneuronal Aβ rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice (2008) · cites this paper as [25]
Citations
Cites
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Asher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,290
THE ASCENDING CHOLINERGIC RETICULAR SYSTEM: NEOCORTICAL, OLFACTORY AND SUBCORTICAL PROJECTIONS
SHUTE, C. C. D., & LEWIS, P. R. (1967) · Brain · doi:10.1093/brain/90.3.497 · Cited by 1,118
NECROPSY EVIDENCE OF CENTRAL CHOLINERGIC DEFICITS IN SENILE DEMENTIA
Perry, E., Perry, R., Blessed, G., & Tomlinson, B. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91780-9 · Cited by 1,069
Dementia of the Alzheimer Type
Terry, R. D., & Davies, P. (1980) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.03.030180.000453 · Cited by 529
NEOCORTICAL CHOLINERGIC NEURONS IN ELDERLY PEOPLE
White, P., Goodhardt, M. J., Keet, J. P., Hiley, C. R., Carrasco, L. H., Williams, I. E. I., & Bowen, D. M. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92114-6 · Cited by 489
Divac, I. (1975) · Brain Research · doi:10.1016/0006-8993(75)90178-x · Cited by 488
Evidence for a cholinergic projection to neocortex from neurons in basal forebrain.
Johnston, M. V., McKinney, M., & Coyle, J. T. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.10.5392 · Cited by 460
Self-citationAcetylcholinesterase-rich projections from the basal forebrain of the rhesus monkey to neocortex
Mesulam, M.-M., & Van Hoesen, G. W. (1976) · Brain Research · doi:10.1016/0006-8993(76)90385-1 · Cited by 426
Jones, E. G., Burton, H., Saper, C. B., & Swanson, L. W. (1976) · Journal of Comparative Neurology · doi:10.1002/cne.901670402 · Cited by 420
Research works printed but not linked: 2
- von Buttlar‐Brentano K, 1955, Das Parkinsonsyndrom im Lichte der lebensgeschichtlichen Veränderungen des Nucleus basalis, J Hirnforsch, 2, 55
- Meynert T, 1872, Stricker's Handbuch der Lehre von den Geweben
Cited by
Items 901–1,000 of 1,001
Tumor Necrosis Factor and Alzheimer's Disease: A Cause and Consequence Relationship
Sharma, V., Thakur, V. B. S., Singh, S. N., & Guleria, R. (2012) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20120112064639 · Cited by 30
McKeever, P. M., Kim, T. P., Hesketh, A. R., MacNair, L., Miletic, D., Favrin, G., Oliver, S. G., Zhang, Z., George‐Hyslop, P. S., & Robertson, J. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.05.014 · Cited by 29
Treatment of mild cognitive impairment: rationale, present and future strategies
Jelić, V., & Winblad, B. G. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.107.s179.12.x · Cited by 31
Cholinergic neuronal loss in the globus pallidus of Alzheimer disease patients
Lehéricy, S., Hirsch, É. C., Hersh, L. B., & Agid, Y. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90918-j · Cited by 31
Sreekumaran, E., Ramakrishna, T., Madhav, T. R., Anandh, D., Prabhu, B. M., Sulekha, S., Bindu, P., & Raju, T. R. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(02)00944-9 · Cited by 31
Anti‐amnesic effect of dimemorfan in mice
Wang, H., Chien, J., Chou, Y., Liao, J., & Chen, C. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705117 · Cited by 27
Cortical and subcortical diseases: Do true neuropsychological differences exist?☆
Arango‐Lasprilla, J. C., Rogers, H. L., Lengenfelder, J., DeLuca, J., MORENO, S., & LOPERA, F. (2005) · Archives of Clinical Neuropsychology · doi:10.1016/j.acn.2005.07.004 · Cited by 27
Butt, A. E., Noble, M. M., Rogers, J. L., & Rea, T. E. (2002) · Behavioral Neuroscience · doi:10.1037//0735-7044.116.2.241 · Cited by 27
Yamamoto, J. (1988) · The Japanese Journal of Pharmacology · doi:10.1016/s0021-5198(19)43226-5 · Cited by 27
Cognitive and Psychiatric Abnormalities in Multiple Sclerosis
Petersen, R. C., & Kokmen, E. (1989) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)65344-0 · Cited by 27
Resurrecting the Autopsy: Benefits and Recommendations
Nemetz, P. N., Beard, C. M., Ballard, D. J., Ludwig, J., Tangalos, E. G., Kokmen, E., WEIGEL, K. M., BELAU, P. G., Bourne, W. M., & Kurland, L. T. (1989) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)64975-1 · Cited by 27
Ebert, U., Oertel, R., Wesnes, K. A., & Kirch, W. (1998) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199804)13:3<199::aid-hup974>3.0.co;2-3 · Cited by 27
Price, D. L., Cork, L. C., Struble, R. G., Whitehouse, P. J., Kitt, C. A., & Walker, L. C. (1985) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1985.tb37597.x · Cited by 27
Self-citationLocal cerebral glucose utilization in the brain of old, learning impaired rats
Wree, A., Kaever, C., Birgel, B., Schleicher, A., Horváth, E. J., & Zilles, K. (1991) · Histochemistry and Cell Biology · doi:10.1007/bf00266747 · Cited by 27
Szwajgier, D., Borowiec, K., & Zapp, J. (2020) · Zeitschrift für Naturforschung C · doi:10.1515/znc-2019-0079 · Cited by 26
Research progress of plant‐derived natural alkaloids in central nervous system diseases
Zhang, Q., Jiang, Q., Sa, K., Liang, J., Sun, D., Li, H., & Chen, L. (2023) · Phytotherapy Research · doi:10.1002/ptr.7955 · Cited by 29
Cholinergic axon length reduced by 300 meters in the brain of an Alzheimer mouse model
Nikolajsen, G. N., Jensen, M. S., & West, M. J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.05.006 · Cited by 27
Latina, V., Caioli, S., Zona, C., Ciotti, M. T., Borreca, A., Calissano, P., & Amadoro, G. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00487 · Cited by 26
Jeyachandran, V., Kumar, R. R., Ali, M. A., & Choon, T. S. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.01.122 · Cited by 26
Donepezil induces a cholinergic sprouting in basocortical degeneration
Ginestet, L., Ferrario, J. E., Raisman‐Vozari, R., Hirsch, É. C., & Debeir, T. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04497.x · Cited by 27
Bailey, A. M., Rudisill, M. L., Hoof, E. J., & Loving, M. L. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02294-7 · Cited by 29
Acetylcholinesterase inhibition by zifrosilone: Pharmacokinetics and pharmacodynamics*
Cutler, N. R., Seifert, R. D., Schleman, M. M., Sramek, J. J., Szylleyko, O. J., Howard, D. R., Barchowsky, A., Wardle, T. S., & Brass, E. P. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90072-1 · Cited by 26
Intermediary metabolism disturbance in AD/SDAT and its relation to molecular events
Hoyer, S. (1993) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(93)90043-r · Cited by 29
Use of Antidementia Agents in Vascular Dementia: Beyond Alzheimer Disease
Farlow, M. R. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.10.1350 · Cited by 27
Selective attention in Alzheimer's disease
Jonathan, K. (2001) · Frontiers in bioscience · doi:10.2741/foster · Cited by 26
Marotta, C. A., Majocha, R. E., Coughlin, J. F., Manz, H. J., Davies, P., Ventosa-Michelman, M., Chou, W., Zain, S. B., & Sajdel, E. M. (1986) · Progress in brain research · doi:10.1016/s0079-6123(08)64312-5 · Cited by 26
Metrifonate: Overview of Safety and Efficacy
Cummings, J. L. (1998) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1998.tb03877.x · Cited by 26
Clinical brain imaging with isopropyl-iodoamphetamine and SPECT
Royal, H. D., Hill, T., & Holman, B. L. (1985) · Seminars in Nuclear Medicine · doi:10.1016/s0001-2998(85)80014-3 · Cited by 26
Smith, C. G., Beninger, R. J., Mallet, P. E., Jhamandas, K. H., & Boegman, R. J. (1994) · Brain Research · doi:10.1016/0006-8993(94)90282-8 · Cited by 26
Age-related neurofilament phosphorylation in normal human brains
Blanchard, B. J., & Vm, I. (1989) · Neurobiology of Aging · doi:10.1016/0197-4580(89)90059-6 · Cited by 26
Sun, F., Zhao, J. J., Zhang, H., Shi, Q., Liu, Y., Robert, A., Liu, Q., & Meunier, B. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00455 · Cited by 25
Converting maslinic acid into an effective inhibitor of acylcholinesterases
Schwarz, Š., Loesche, A., Lucas, S. D., Sommerwerk, S., Serbian, I., Siewert, B., Pianowski, E., & Csük, R. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.09.007 · Cited by 26
Cutuli, D., Landolfo, E., Decandia, D., Nobili, A., Viscomi, M. T., Barbera, L. L., Sacchetti, S., Bartolo, P. D., Curci, A., D’Amelio, M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051741 · Cited by 26
Etheredge, J., Murchison, D. A., Abbott, L. C., & Griffith, W. H. (2005) · Brain Research · doi:10.1016/j.brainres.2005.11.007 · Cited by 25
Grossberg, G. T. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x65402 · Cited by 26
Szigethy, E., Quirion, R., & Beaudet, A. (1990) · The Journal of Comparative Neurology · doi:10.1002/cne.902970403 · Cited by 26
Neurogenesis of the magnocellular basal forebrain nuclei in the rhesus monkey
Kordower, J. H., & RAKIC, P. T. (1990) · The Journal of Comparative Neurology · doi:10.1002/cne.902910410 · Cited by 25
Zhan, S., Kamphorst, W., Nostrand, W. E. V., & Eikelenboom, P. (1995) · Acta Neuropathologica · doi:10.1007/bf00309629 · Cited by 25
Butt, A. E., & Hodge, G. K. (1997) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00062-4 · Cited by 25
Ogawa, N., Asanuma, M., Mizukawa, K., Hirata, H., Chou, H., & Mori, A. (1992) · Brain Research · doi:10.1016/0006-8993(92)90993-j · Cited by 25
Pirenzepine-insensitive muscarinic autoreceptors regulate acetylcholine release in human neocortex
Marchi, M., Ruelle, A., Andrioli, G. C., & Raiteri, M. (1990) · Brain Research · doi:10.1016/0006-8993(90)91728-y · Cited by 25
Patricio-Martínez, A., Patricio, F., Macuil-Chapuli, E., Martínez-Juárez, E. Á., Flores-Díaz, S., Cedillo-Ramirez, M. L., & Limón, I. D. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1598011 · Cited by 28
Heme Oxygenase 1 Induces Tau Oligomer Formation and Synapse Aberrations in Hippocampal Neurons
Si, Z., Wang, X., Zhang, Z., Wang, J., Li, J., Li, J., Li, L., Li, Y., Peng, Y., Sun, C., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180451 · Cited by 25
Hahm, E.-T., Nagaraja, R. Y., Waro, G., & Tsunoda, S. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.029 · Cited by 29
Glutamate neurotoxicity and Alzheimer's disease
Hardy, J., & Cowburn, R. F. (1987) · Trends in Neurosciences · doi:10.1016/0166-2236(87)90008-7 · Cited by 24
Trans-activation by thyroid hormone receptors of the 5′ flanking region of the human ChAT gene
Quirin‐Stricker, C., Nappey, V., Simoni, P., Toussaint, J.-L., & Schmitt, M. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90232-1 · Cited by 24
Cummings, J. L., & Ringman, J. M. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.4.463 · Cited by 24
Epidermal growth factor affects both glia and cholinergic neurons in septal cell cultures
Kenigsberg, R. L., Mazzoni, I. E., Collier, B., & Cuello, A. C. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90383-d · Cited by 25
Enhanced behavioral response to nicotine in an animal model of Alzheimer's disease
Ksir, C. J., & Benson, D. M. (1983) · Psychopharmacology · doi:10.1007/bf00427277 · Cited by 24
Patterns of synaptic and nerve cell pathology in Alzheimer's disease
Lassmann, H. (1996) · Behavioural Brain Research · doi:10.1016/0166-4328(95)00215-4 · Cited by 24
Neurotransmitter Receptor Alterations in Alzheimer’s Disease
Whitehouse, P. J., & Au, K. S. (1985) · Advances in applied neurological sciences · doi:10.1007/978-3-642-70644-8_14 · Cited by 24
Self-citationMolecular biology and neurobiology of choline acetyltransferase
Salvaterra, P. M. (1987) · Molecular Neurobiology · doi:10.1007/bf02936610 · Cited by 26
Sørensen, J. C. H., Wanner-Olsen, H., Tønder, N., Danielsen, E. H., Castro, A. J., & Zimmer, J. (1990) · Experimental Brain Research · doi:10.1007/bf02423503 · Cited by 26
Effects of Selective Immunotoxic Lesions on Learning and Memory
Baxter, M. G. (2003) · Humana Press eBooks · doi:10.1385/1-59259-114-0:249 · Cited by 29
Chemical Neuroanatomy of Alzheimer’s Disease
Saper, C. B. (1988) · Springer eBooks · doi:10.1007/978-1-4613-0933-8_4 · Cited by 29
Yan, H., Pang, P., Chen, W., Zhu, H., Afewerky, H. K., Li, H., Wu, Z., Ke, X., Wu, J., Zhang, T., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0672-6 · Cited by 24
Nguyen, H. T. M., van der Westhuizen, E. T., Langmead, C. J., Tobin, A. B., Sexton, P. M., Christopoulos, A., & Valant, C. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15982 · Cited by 25
Hu, Y., Chen, X., Zhang, Y., McGurran, H., Stormmesand, J., Breeuwsma, N., Sluiter, A. A., Zhao, J., Swaab, D. F., & Bao, A. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1117584 · Cited by 23
A review of structural modification and biological activities of oleanolic acid
Yang, H., Deng, M., Jia, H., Zhang, K., Liu, Y., Cheng, M., & Xiao, W. (2024) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(24)60559-5 · Cited by 30
McNeely, A. A., Ramirez, J., Nestor, S. M., Zhao, J., Gao, F., Kiss, A., Stuss, D. T., & Black, S. E. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140588 · Cited by 25
Behavioral and biochemical evidences for nootropic activity of boldine in young and aged mice
Dhingra, D., & Soni, K. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.11.011 · Cited by 23
Hameed, A., Zehra, S. T., Abbas, S., Nisa, R. U., Mahmood, T., Ayub, K., al‐Rashida, M., Bajorath, J., Khan, K. M., & Iqbal, J. (2016) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2016.01.004 · Cited by 23
Cholinergic Dysfunction in Alzheimer Disease: Cause or Effect?
Plotkin, D. A., & Jarvik, L. F. (1986) · Progress in brain research · doi:10.1016/s0079-6123(08)60644-5 · Cited by 24
The treatment of Alzheimer's disease
Allen, N. H. P., & Burns, A. S. (1995) · Journal of Psychopharmacology · doi:10.1177/026988119500900108 · Cited by 26
Ellis, J. R., Nathan, P. J., Villemagne, V. L., Mulligan, R. S., Saunder, T., Young, K., Smith, C. S., Welch, J., Woodward, M., Wesnes, K. A., et al. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1347-9 · Cited by 27
Effects of acute doses of oxiracetam in the scopolamine model of human amnesia
Preda, L., Alberoni, M., Bressi, S., Cattaneo, C., Parini, J., Canal, N., & Franceschi, M. (1993) · Psychopharmacology · doi:10.1007/bf02244648 · Cited by 23
Nerve growth factor and the neostriatum
Altar, C. A. (1991) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(91)90077-e · Cited by 23
Selective attention in Alzheimer's disease: CSF correlates of behavioral impairments
Freed, D. M., Corkin, S., Growdon, J. H., & Nissen, M. J. (1988) · Neuropsychologia · doi:10.1016/0028-3932(88)90057-7 · Cited by 23
The Neuropathology of Alzheimer’s Disease
Lantos, P. L., & Cairns, N. J. (1994) · Springer eBooks · doi:10.1007/978-1-4615-6805-6_12 · Cited by 25
Davis, R. E., Raby, C. A., Callahan, M. J., Lipinski, W. J., Schwarz, R. D., Dudley, D. T., Lauffer, D. J., Reece, P. A., Jaén, J. C., & Tecle, H. (1993) · Progress in brain research · doi:10.1016/s0079-6123(08)62430-9 · Cited by 23
Ogawa, N., Asanuma, M., Kondo, Y., Nishibayashi, S., & Mori, A. (1994) · Brain Research · doi:10.1016/s0006-8993(09)90013-0 · Cited by 23
Varshney, V., & Garabadu, D. (2021) · Neuropeptides · doi:10.1016/j.npep.2021.102122 · Cited by 22
Wang, Y., Zhan, M., Roebroeck, A. F., Weerd, P. D., Kashyap, S., & Roberts, M. J. (2022) · NeuroImage · doi:10.1016/j.neuroimage.2022.119421 · Cited by 24
de Leo, G., Gulino, R., Coradazzi, M., & Leanza, G. (2022) · Brain Communications · doi:10.1093/braincomms/fcac338 · Cited by 22
Magherini, A., & Litvan, I. (2005) · Neurocase · doi:10.1080/13554790590962979 · Cited by 22
Human Embryonic Stem Cell Therapies for Neurodegenerative Diseases
Tomaskovic‐Crook, E., & Crook, J. M. (2011) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152711795564001 · Cited by 22
Varshney, V., & Garabadu, D. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06447-1 · Cited by 22
Yoo, D.-H., & Kim, D. (2015) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2015.1064865 · Cited by 22
Figueiró, M., Ilha, J., Pochmann, D., Porciúncula, L. O., Xavier, L. L., Achaval, M., Nunes, D. S., & Elisabetsky, E. (2010) · Phytomedicine · doi:10.1016/j.phymed.2010.03.009 · Cited by 22
Lamirault, L., Guillou, C., Thal, C., & Simon, H. (2003) · Neurobiology of Learning and Memory · doi:10.1016/s1074-7427(03)00064-9 · Cited by 24
Concurrent administration of atypical antipsychotics and donepezil: drug interaction study in rats
Nirogi, R. V. S., Bhyrapuneni, G., Kandikere, V. N., Benade, V. S., Muddana, N., Saralaya, R., Irappanavar, S. M., Ponnamaneni, R. K., & Mukkanti, K. (2012) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-012-0081-1 · Cited by 22
EEG power spectrum typical of vascular dementia in a subgroup of Alzheimer patients
Signorino, M., Pucci, E., Brizioli, E., Cacchiò, G., Nolfe, G., & Angeleri, F. (1996) · Archives of Gerontology and Geriatrics · doi:10.1016/0167-4943(96)00714-5 · Cited by 22
Saragovi, H. U. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03479.x · Cited by 22
An unusually glycosylated form of acetylcholinesterase is a CSF biomarker for Alzheimer's disease
Sáez‐Valero, J., Ss, S. S. S., & Small, D. H. (2000) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2000.00307.x · Cited by 22
Chronic administration of acetylcholinesterase inhibitor in the senescent Rat brain
Tanaka, K., Ogawa, N., Asanuma, M., Kondo, Y., & Mori, A. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90054-x · Cited by 22
Regional age-related alterations in cholinergic and GABAergic receptors in the rat brain
Araki, T., Kato, H., Fujiwara, T., & Itoyama, Y. (1996) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(96)01720-4 · Cited by 22
Qualitative abnormalities of choline acetyltransferase in Alzheimer type dementia
Koshimura, K., Kato, T., Tohyama, I., Nakamura, S., & Kameyama, M. (1986) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(86)90164-4 · Cited by 24
Cholinergic topography in Alzheimer brains: a comparison with changes in the monoaminergic profile
Nordberg, A. K., Nyberg, P., Adolfsson, R., & Winblad, B. G. (1987) · Journal of Neural Transmission · doi:10.1007/bf01244094 · Cited by 22
Mann, D. M. A., & Yates, P. O. (1982) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.45.10.936 · Cited by 22
Pearlson, G. D., & Tune, L. E. (1986) · Psychiatry Research · doi:10.1016/0165-1781(86)90038-7 · Cited by 23
Kokmen, E. (1984) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)60340-1 · Cited by 26
Nguyen, V. T. T., Sallbach, J., Guilherme, M. D. S., & Endres, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031015 · Cited by 22
Cognitive Deficits in Aging Related to Changes in Basal Forebrain Neuronal Activity
Chaves‐Coira, I., García‐Magro, N., Zegarra-Valdivia, J. A., Torres‐Alemán, I., & Núñez, Á. (2023) · Cells · doi:10.3390/cells12111477 · Cited by 22
The basal forebrain cholinergic system as target for cell replacement therapy in Parkinson’s disease
Björklund, A., & Barker, R. A. (2024) · Brain · doi:10.1093/brain/awae026 · Cited by 22
Blockade of muscarinic receptors impairs the retrieval of well-trained memory
Soma, S., Suematsu, N., & Shimegi, S. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00063 · Cited by 22
Broks, P., Lines, C., Atchison, L., Challenor, J., Traub, M., Foster, C., & SAGAR, H. J. (1996) · Behavioural Neurology · doi:10.1155/1996/374983 · Cited by 24
Cholinesterase inhibitors modify the activity of intrinsic cardiac neurons
Darvesh, S., Arora, R. C., Martin, E. V., MaGee, D. I., Hopkins, D. A., & Armour, J. A. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.05.002 · Cited by 21
Computer-assisted 3D reconstruction of the human basal forebrain complex
Grinberg, L. T., & Heinsen, H. (2007) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642008dn10200005 · Cited by 24
Global actions of nicotine on the striatal microcircuit
Plata, V. T. G., Duhne, M., Pérez-Ortega, J., Hernandez-Martinez, R., Rueda‐Orozco, P. E., Galarraga, E., Drucker-Colín, R., & Bargas, J. (2013) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2013.00078 · Cited by 22
Neuronal Loss and Neurotransmitter Receptor Alterations in Alzheimer’s Disease
Whitehouse, P. J. (1986) · Advances in behavioral biology · doi:10.1007/978-1-4613-2179-8_11 · Cited by 23
Self-citation
Metadata
- Authors
- Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Whitehouse, Peter J.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1981-08
- Volume
- 10
- Issue
- 2
- Pages
- 122-126
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1982064952
- Cited by
- 1,736
- References
- 23
- Citations by year
- 2026: 24 · 2025: 34 · 2024: 31 · 2023: 43 · 2022: 31 · 2021: 64 · 2020: 40 · 2019: 37 · 2018: 42 · 2017: 24 · 2016: 41 · 2015: 21 · 2014: 38 · 2013: 47 · 2012: 31
- FWCI
- 48.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Keywords
- Alzheimer's disease, nucleus basalis of Meynert, cholinergic neurons, neuronal loss, cholinergic degeneration, anatomical correlates
- MeSH terms
- Aged, Alzheimer Disease, Basal Ganglia, Cell Count, Cholinergic Fibers, Dementia, Humans, Male
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.